Eli Lilly & Co. and Novo Nordisk A/S have struck a deal with the Trump administration to lower prices for their popular weight-loss drugs, Zepbound and Wegovy, while gaining tariff relief and expanding Medicare access. This agreement aims to increase availability for older Americans.
In a groundbreaking move, the Trump administration has announced new agreements with Novo Nordisk and Eli Lilly to significantly reduce the cost of GLP-1 medications for American patients, including those on Medicare. With prices set to drop dramatically, millions will soon benefit from affordable access to essential treatments.
In a groundbreaking move, President Trump has negotiated significant price reductions for popular weight loss medications, bringing costs down to as low as $50 per month for eligible patients. Find out how these changes will affect access to essential treatments!
In a groundbreaking move, President Trump announces deals with Eli Lilly and Novo Nordisk to reduce obesity drug prices, making treatments more accessible for millions of Americans. Medicare coverage for GLP-1 drugs starts in 2026, changing the landscape of obesity treatment.
The Social Security Administration's 2.8% benefits increase for 2026 may fall short for Seattle residents facing high living costs. Experts warn that inflation and rising Medicare premiums could diminish the impact of this adjustment.
In a significant move, the Social Security Administration has announced a 2.8% increase in benefits for 2026, aimed at helping retirees cope with rising costs. However, many seniors may find that increased Medicare premiums will offset this gain, leaving them financially vulnerable. Discover the implications of this adjustment for millions of Americans.
In 2026, Social Security benefits will rise by 2.8%, adding an average of $56 monthly. Learn how to estimate your new benefits and what factors may affect your payments.
In a bold move to reduce U.S. prescription drug prices, AstraZeneca and Pfizer have struck deals with the White House, promising significant discounts for patients. This comes amid rising pressure from President Trump on drugmakers to lower costs or face hefty tariffs. Will these changes truly benefit American patients?
As federal subsidies for health insurance face expiration, Idaho residents like Susan Wood warn of skyrocketing premiums and potential loss of coverage. Thousands could be affected as Congress debates the future of healthcare funding.
Get ready for a smooth COVID-19 vaccine season! The CDC confirms access for everyone aged 6 months and older, with no prescription required. Discover what to expect and how to get your shot easily this year.